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Background
It is known that better glycemic control reduces the
chronic complications of diabetes (DM). The target of the
glycemic control is difficult to achieve, and only 25-50% of
the patients achieve the goals. Some studies show that dif-
ferent devices for insulin can improve the adherence.
Objectives
Evaluate the glycemic response after changing the insu-
lin syringes (SY) for pens device (PD) in patients chroni-
cally decompensated already in insulin use.
Materials and methods
This is a prospective, intervention, non-randomized, phase
IV study. We included patients over 60 yrs. old, both
sexes, with HbA1c >8.5% using oral hypoglycemic agents
and insulin and then we replaced SY by PD. We used
human insulin NPH and regular as pens, all patients have
received a blood glucose monitor, lancet tapes, capillary
blood glucose tests (3 tests/day). HbA1c was measured at
baseline, 3 and 6 months. Patients were seen monthly.
Results
Analysis was “intention-to-treat” of the 45 patients
included. HbA1c, at baseline was 10.34±0.22, similar to
the values 12 and 6 months prior to inclusion. HbA1c
was 8.54±0.23 and 8.09±0.21, after 3 and 6 months,
respectively, with no difference among them. After
3 months of the end of study, there was a deterioration
of HbA1c (9.67±0.38). Patients remained using PD. Dur-
ing the study, there was an increase in total daily insulin
dose prescribed (0.84±0.07 to 1.06±0.10UI/kg, p<0.001)
and increase in regular/NPH insulin ratio (0.12±0.02 to
1.22±0.04, p=0.001), with no increasing of BMI
(31.7±0.72 vs. 32.13±0.79kg/m2, p=0.82). Moreover, we
found no difference in the occurrence of hypoglycemia
(p=1.00), at baseline and at the end of study. Regarding
blood pressure was not significantly different among vis-
its. We also evaluated quality of life and psychological
stress associated with DM with standardized question-
naires, which were not different between the first and
last visits.
Conclusion
More frequent medical visits, provision of inputs for the
treatment, including the use of PD and performing self-
monitoring favored glycemic control. The glycemic goal
has been achieved in this group of elderly patients with
DM (with a reduction of 2.25% in average HbA1C at
6 months) with increased doses of insulin, especially
regular insulin, no significant increase in hypoglycemia.
Our data suggest that a change in the management of
chronic decompensated elderly diabetics is required.
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